GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Accupril

Company
Baylor Research Institute
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Accupril and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02817360

    NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

    Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites
    Type 2 diabetes Other conditions: Heart Diseases
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT00147524

    Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women

    Not yet reported Pfizer 70 participants Est. completion 2005-05 5 sites
    Other conditions: Menopause, Hypertension
    View official trial listing →
  • Completed NCT NCT00150826

    QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia

    Not yet reported University of Florida 78 participants Est. completion 2004-12 1 site
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00154050

    High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty

    Not yet reported Technische Universität Dresden 22 participants Est. completion 2006-07 1 site
    Other conditions: Arterial Occlusive Diseases
    View official trial listing →
  • Completed NCT NCT00159692

    Amlodipine Diabetic Hypertension Efficacy Response Trial

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 739 participants Est. completion 2005-08
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00269243

    Management With Accupril Post Bypass Graft

    Not yet reported Montreal Heart Institute Est. completion 2005-05
    Other conditions: CABG
    View official trial listing →
  • Completed NCT NCT00295542

    Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

    Not yet reported University of Vigo 3344 participants Est. completion 2009-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00313547

    High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

    Not yet reported Montreal Heart Institute 40 participants Est. completion 2008-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00438113

    Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF

    Not yet reported Nova Scotia Health Authority 184 participants Est. completion 2016-09 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00648011

    Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 44 participants Est. completion 2003-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649103

    Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg

    Not yet reported Mylan Pharmaceuticals Inc 60 participants Est. completion 2003-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649441

    Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 60 participants Est. completion 2003-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649649

    Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg

    Not yet reported Mylan Pharmaceuticals Inc 24 participants Est. completion 2003-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00651287

    A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension

    Not yet reported Pfizer 200 participants Est. completion 2004-06 3 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00684489

    Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

    Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00741585

    Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

    Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sites
    Cardiovascular diseaseChronic kidney disease Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00795262

    Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension

    Not yet reported InVasc Therapeutics, Inc. 23 participants Est. completion 2009-07 1 site
    Other conditions: Diabetes, Hypertension
    View official trial listing →
  • Completed NCT NCT00872235

    Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2005-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00872781

    Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 64 participants Est. completion 2007-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00930722

    A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population

    Pfizer 329 participants Est. completion 2010-06 18 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00980187

    A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM

    Not yet reported LaborMed Pharma S.A. 56 participants Est. completion 2010-08 1 site Stand-alone
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01581476

    Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial

    Not yet reported University of Cambridge 443 participants Est. completion 2017-06 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01669434

    Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

    Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site
    Other conditions: Hypotension on Induction
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01867047

    ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients

    Not yet reported Duke University 59 participants Est. completion 2016-06-24 1 site Stand-alone
    Other conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension
    View official trial listing →
  • Completed NCT NCT03031834

    Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus

    Not yet reported Aristotle University Of Thessaloniki
    Other conditions: Diabetic Autonomic Neuropathy
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Completed NCT NCT05713396

    Diabetic Autonomic Neuropathy and Left Ventricular Function

    Not yet reported AHEPA University Hospital 59 participants Est. completion 2022-06-01 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT06515678

    Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

    Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites
    Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Enrolling by invitation NCT NCT07547878

    Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Accupril, Quinapril

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.